Visiomed Group SA [ALVMG] vs Bonyf N.V [MLBON] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Visiomed Group SA wins in 8 metrics, Bonyf N.V. wins in 1 metrics, with 3 ties. Visiomed Group SA appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Visiomed Group SA | Bonyf N.V. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 59.67 | N/A | N/A |
| Price-to-Book Ratio | N/A | 5.72 | N/A |
| Debt-to-Equity Ratio | 0.32 | 0.00 | Tie |
| EV/EBITDA | 13.79 | 0.00 | Tie |
| Profit Margin (TTM) | 45.95% | 8.02% | Visiomed Group SA |
| Operating Margin (TTM) | 19.87% | -12.90% | Visiomed Group SA |
| EBITDA Margin (TTM) | 19.87% | N/A | N/A |
| Return on Equity | 3.64% | -32.61% | Visiomed Group SA |
| Return on Assets (TTM) | 2.46% | -0.69% | Visiomed Group SA |
| Free Cash Flow (TTM) | $-1.50M | $56.95M | Bonyf N.V. |
| 1-Year Return | 11.11% | -73.29% | Visiomed Group SA |
| Price-to-Sales Ratio (TTM) | 3.85 | 8.03 | Visiomed Group SA |
| Enterprise Value | $57.79M | $0 | Visiomed Group SA |
| EV/Revenue Ratio | 4.22 | 0.00 | Tie |
| Revenue per Share (TTM) | $0 | N/A | N/A |
| Earnings per Share (Diluted) | $0.00 | $-1.77 | Visiomed Group SA |
| Beta (Stock Volatility) | N/A | -0.03 | N/A |
Visiomed Group SA vs Bonyf N.V. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Visiomed Group SA | -3.05% | 5.26% | 5.26% | 11.11% | 11.11% | 11.11% |
| Bonyf N.V. | -0.47% | -0.47% | -0.47% | -6.25% | -67.44% | -14.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Visiomed Group SA | 11.11% | 11.11% | 11.11% | 11.11% | 11.11% | 11.11% |
| Bonyf N.V. | -73.29% | -64.83% | -66.24% | -66.24% | -66.24% | -66.24% |
Performance & Financial Health Analysis: Visiomed Group SA vs Bonyf N.V.
| Metric | ALVMG | MLBON |
|---|---|---|
| Market Information | ||
| Market Cap | €52.83M | €2.48M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 371,925 | 2 |
| 90 Day Avg. Volume | 628,133 | 1 |
| Last Close | €0.19 | €4.20 |
| 52 Week Range | €0.15 - €0.31 | €3.96 - €15.80 |
| % from 52W High | -37.89% | -73.42% |
| All-Time High | €173.86 (Dec 15, 2014) | €19.50 (Feb 17, 2025) |
| % from All-Time High | -99.89% | -78.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.46% | 0.08% |
| Operating Margin (TTM) | 0.20% | -0.13% |
| Return on Equity (TTM) | 0.04% | -0.33% |
| Debt to Equity (MRQ) | 0.32 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | €0.74 |
| Cash per Share (MRQ) | N/A | N/A |
| Operating Cash Flow (TTM) | €-1,308,000 | €56.95M |
| Levered Free Cash Flow (TTM) | €902,000 | €-36,509 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Visiomed Group SA vs Bonyf N.V.
| Metric | ALVMG (Apr 11, 2026) | MLBON (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 59.67 | N/A |
| Forward P/E | 5.75 | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 3.85 | 8.03 |
| Price to Book (MRQ) | N/A | 5.72 |
| Market Capitalization | ||
| Market Capitalization | €52.83M | €2.48M |
| Enterprise Value | €57.79M | €0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.22 | 0.00 |
| Enterprise to EBITDA | 13.79 | 0.00 |
| Risk & Other Metrics | ||
| Beta | N/A | -0.03 |
| Book Value per Share (MRQ) | N/A | €0.74 |
Financial Statements Comparison: Visiomed Group SA vs Bonyf N.V.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ALVMG (2023) | MLBON (2024) |
|---|---|---|
| Revenue/Sales | 13.71M | 281,483 |
| Cost of Goods Sold | 7.41M | 258,907 |
| COGS % of Revenue | 54.0% | 92.0% |
| Gross Profit | 6.30M | 22,575 |
| Gross Margin | 46.0% | 8.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 952,000 | -34,713 |
| Operating Margin | 6.9% | -12.3% |
| EBITDA | 4.19M | -33,732 |
| EBITDA Margin | 30.6% | -12.0% |
| Pre-Tax Income | 1.52M | -36,509 |
| Pre-Tax Income % of Revenue | 11.1% | -13.0% |
| Income Tax | -37,000 | N/A |
| Income Tax % of Revenue | -0.3% | 0.0% |
| Net Income (Profit) | 902,000 | -36,509 |
| Profit Margin | 6.6% | -13.0% |
Balance Sheet & Liquidity Metrics
| Metric | ALVMG (2023) | MLBON (2024) |
|---|---|---|
| Cash & Equivalents | 2.97M | 5,029 |
| Total Current Assets | 5.28M | 340,897 |
| Total Current Assets % of Revenue | 38.5% | 121.1% |
| Total Current Liabilities | 3.38M | 674,661 |
| Total Current Liabilities % of Revenue | 24.7% | 239.7% |
| Long-Term Debt | 7.64M | N/A |
| Long-Term Debt % of Revenue | 55.7% | 0.0% |
| Total Shareholders Equity | 24.75M | 2.64M |
| Retained Earnings | 902,000 | -4.43M |
| Retained Earnings % of Revenue | 6.6% | -1,572.4% |
| Property, Plant & Equipment | 7.30M | N/A |
Cash Flow Statement Comparison
| Metric | ALVMG (2023) | MLBON (2024) |
|---|---|---|
| Operating Cash Flow | -1.31M | 56.95M |
| Operating Cash Flow % of Revenue | -9.5% | 20,233.8% |
| Capital Expenditures | -1.83M | N/A |
| Free Cash Flow | -1.50M | 56.95M |
| FCF Margin | -10.9% | 20,233.8% |
| Debt Repayment | -1.29M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALVMG | MLBON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 294.17M | 588,600 |
| Float Shares | N/A | N/A |
| % Held by Insiders | N/A | N/A |
| % Held by Institutions | N/A | N/A |
| % Held by Public | N/A | N/A |
Dividend Analysis & Yield Comparison: Visiomed Group SA vs Bonyf N.V.
| Metric | ALVMG | MLBON |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |